/Companies

Dotmatics

1 known investors

Find your way into Dotmatics

Sign up to see every warm intro you have to Dotmatics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Dotmatics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Dotmatics provides a scientific research informatics platform for biologics drug discovery, offering end-to-end data management and analysis across therapeutics such as antibodies, CAR-T cells, and RNA therapeutics. Its biology solution covers workflows including molecular cloning, vector design, protein production, biologics registration, assays, and results analysis for research scientists and R&D organizations.

Investors · 1

Frequently asked questions

What does Dotmatics do?
Dotmatics provides a scientific research informatics platform for biologics drug discovery, offering end-to-end data management and analysis across therapeutics such as antibodies, CAR-T cells, and RNA therapeutics. Its biology solution covers workflows including molecular cloning, vector design, protein production, biologics registration, assays, and results analysis for research scientists and R&D organizations.
Who are Dotmatics's investors?
Dotmatics's investors include Scottish Equity Partners.